KENYA – Dawa Group has rebranded into Dawa Life Sciences, incorporating Dawa Pharmaceuticals, Dawa Animal Health and Dawa Chemicals with one big ambition to provide better quality life for all. With a footprint in 11 countries, revenues of US$60 million in 2020 from over 1,000 product lines, and supply capacity of over 110 million packs of medication, Dawa Group has a vision to become a reference for pharmaceuticals in Africa. Dawa Group has its origins in Medisel Kenya Limited which, in 1994, was founded as a pharmaceutical trading business in…
Read MoreDawa Group rebrands to Dawa Life Sciences as it seeks ambitious regional growth
